Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Gubra: Understanding valuation (PoS) post Abbvie deal

Gubra

The company combines the best of both worlds – a fast-growing, cash-generating CRO business serving top pharma companies and a high-risk, high-reward drug discovery pipeline. A landmark partnership with AbbVie, which includes upfront payments of USD 350m for its obesity drug, GUBamy, highlights its innovation potential.

With advanced AI platforms and new candidates like UCN2 in the pipeline, Gubra is positioned at the frontier of biotech. Watch the video to understand what the market is pricing in – and what could unlock further development? 

Disclaimer: HC Andersen Capital receives payment from Gubra for a DigitalIR/Corporate Visibility subscription agreement. The commentary is for informational purposes only and does not contain recommendations to buy, not to buy, sell or not to sell shares. / Philip Coombes 08:55 26/03/2025

Hexicon Q1´25: Marknaden visar tecken på återhämtning men framtiden är oviss
2025-05-28 11:47 Hexicon
Verve Group, Audiocast, Q1'25
2025-05-28 10:00 Verve
Hexicon, Webcast, Q1'25
2025-05-28 10:00 Hexicon
Sivers-Semiconductors, Capital Markets Day, CMD, 2025
2025-05-27 14:00 Sivers Semiconductors
Raisio's Capital Markets Day 2025
2025-05-27 09:00 Raisio
Titta på alla videos
Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Our team
  • Inderes som en investering
  • Tjänster för börsbolag
Our platform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.

  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • inderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Följda bolag
    • Teamet

Sekretessinställningar

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.